Europe

NHS Mental Health Apps Library to increase access to psychological therapies

Wednesday, March 25, 2015 03:09 PM

NHS England has launched an initiative to help treat depression and anxiety and improve access to psychological therapies by unveiling the first ever directory of NHS-endorsed digital mental health services. The Mental Health Apps Library features online tools, resources and apps that have a proven track record of effectiveness in improving mental health outcomes.

More... »


New immunotechnology center MI-mAbs launched

Monday, March 16, 2015 01:48 PM

MI-mAbs, a new immunotechnology center designed to accelerate the development of new immunotherapy antibodies against cancer and inflammatory disease and founding member of the France-based Marseille Immunopole (MI) cluster, has announced the signature of the consortium agreement sealing the commitment of its founders: Aix-Marseille Universite (AMU) and its private subsidiary Protisvalor, CNRS, Inserm, the Institute Paoli-Calmettes (IPC); three of their research centers (the Centre d'Immunologie de Marseille-Luminy, the Cancer Research Center of Marseille and the Center for Immunophenomics); Innate Pharma, a European immuno-oncology company; and Sanofi.

More... »


U.K. industry paid $456.7M in 2014 to underwrite medicines bill

Friday, March 13, 2015 12:28 PM

The Association of the British Pharmaceutical Industry (ABPI) and the U.K. Department of Health have announced a fourth quarter payment from industry of $119.3 million to underwrite the growth of the medicines bill under the 2014 Pharmaceutical Price Regulation Scheme (PPRS). This takes the total payment made by industry during 2014 to $456.7 million.

More... »

Seven Bridges Genomics U.K. to receive $2.9M to launch Graph Genome

Wednesday, March 11, 2015 12:24 PM

Seven Bridges Genomics U.K. will receive approximately $2.9 million to complete and launch the world’s first functional Graph Genome reference and suite of related tools, thanks to a Small Business Research Initiative grant from the U.K. Department of Health and Genomics England.

More... »

VolitionRx initiates second prostate cancer study assessing nucleosomics technology

Thursday, March 5, 2015 12:23 PM

VolitionRx, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, has initiated a pilot study to assess the feasibility of VolitionRx's proprietary NuQ assays in detecting prostate cancer. The study is in collaboration with ImmuneHealth, a global biomarker CRO, and is taking place in Belgium.

More... »

AstraZeneca, Cambridge Judge Business School collaborate to support biotech startups

Wednesday, March 4, 2015 09:35 AM

AstraZeneca and the University of Cambridge Judge Business School have announced an agreement to deliver a new “Accelerate Cambridge Life Sciences” program at the business school that will identify, train and mentor start-up ventures in the life sciences.

More... »

Alzheimer's Research U.K. launches three Drug Discovery Institutes

Wednesday, February 18, 2015 11:57 AM

Alzheimer's Research U.K., a dedicated dementia research charity, has announced a $46.3 million Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of CambridgeOxford and University College London (UCL). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer's disease and other dementias.

More... »

eClinicalHealth gains approval for Europe’s first fully remote diabetes trial

Wednesday, February 11, 2015 12:44 PM

eClinicalHealth, a Stirling, Scotland-based technology and consulting company providing innovative clinical trial solutions, has announced the Ethical Committee approval of Verkko in Finland—Europe's first remote clinical study to include full electronic informed consent.

More... »

Genticel to continue per protocol its phase II study with ProCervix after review by DSMB

Thursday, January 29, 2015 10:54 AM

Genticel, a French biotechnology company and developer of therapeutic vaccines, has announced that the Data and Safety Monitoring Board (DSMB), an independent committee of experts which monitors safety data every six months during a study, met as scheduled on Jan. 22. It recommended the RHEIA-VAC study proceed without any modifications. The DSMB already had made the same recommendation during the first review on July 1, 2014.

More... »

genae buys e-novex

Wednesday, January 28, 2015 11:56 AM

genae, a global CRO and services provider, has acquired e-novex, a provider of electronic data tools for medical research. Both companies are based in Antwerp, Belgium.

More... »

`

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs